DA03672/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	1
1993	1
1994	1
1995	3
1996	2
1997	2
1998	6
1999	3
2000	5
2001	3
2002	1
2003	2
2004	3
2005	4
2006	4
2007	3
2008	4
2009	3
2010	2
2015	3
2024	0

1

Lichtman AH, Martin BR. Lichtman AH, et al. Handb Exp Pharmacol. 2005;(168):691-717. doi: 10.1007/3-540-26573-2_24. Handb Exp Pharmacol. 2005. PMID: 16596793 Review.

2

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. Pertwee RG, et al. Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004. Pharmacol Rev. 2010. PMID: 21079038 Free PMC article. Review.

3

Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.

Huffman JW, Miller JR, Liddle J, Yu S, Thomas BF, Wiley JL, Martin BR. Huffman JW, et al. Bioorg Med Chem. 2003 Apr 3;11(7):1397-410. doi: 10.1016/s0968-0896(02)00649-1. Bioorg Med Chem. 2003. PMID: 12628666

4

The endogenous cannabinoid system and its role in nociceptive behavior.

Cravatt BF, Lichtman AH. Cravatt BF, et al. J Neurobiol. 2004 Oct;61(1):149-60. doi: 10.1002/neu.20080. J Neurobiol. 2004. PMID: 15362158 Review.

5

Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.

Huffman JW, Liddle J, Duncan SG Jr, Yu S, Martin BR, Wiley JL. Huffman JW, et al. Bioorg Med Chem. 1998 Dec;6(12):2383-96. doi: 10.1016/s0968-0896(98)80014-x. Bioorg Med Chem. 1998. PMID: 9925296

6

Pharmacological characterization of novel water-soluble cannabinoids.

Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK. Martin BR, et al. J Pharmacol Exp Ther. 2006 Sep;318(3):1230-9. doi: 10.1124/jpet.106.104109. Epub 2006 Jun 6. J Pharmacol Exp Ther. 2006. PMID: 16757541

7

Synthesis and pharmacology of a hybrid cannabinoid.

Huffman JW, Lu J, Dai D, Kitaygorodskiy A, Wiley JL, Martin BR. Huffman JW, et al. Bioorg Med Chem. 2000 Feb;8(2):439-47. doi: 10.1016/s0968-0896(99)00305-3. Bioorg Med Chem. 2000. PMID: 10722167

8

Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

Huffman JW, Bushell SM, Joshi SN, Wiley JL, Martin BR. Huffman JW, et al. Bioorg Med Chem. 2006 Jan 1;14(1):247-62. doi: 10.1016/j.bmc.2005.08.013. Epub 2005 Sep 13. Bioorg Med Chem. 2006. PMID: 16165365

9

Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes.

Pugh G Jr, Welch SP, Bass PP. Pugh G Jr, et al. Pharmacol Biochem Behav. 1994 Dec;49(4):1093-100. doi: 10.1016/0091-3057(94)90270-4. Pharmacol Biochem Behav. 1994. PMID: 7886081

10

Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.

Bass CE, Martin BR. Bass CE, et al. Drug Alcohol Depend. 2000 Aug 1;60(2):113-9. doi: 10.1016/s0376-8716(99)00150-7. Drug Alcohol Depend. 2000. PMID: 10940538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year